Organogenesis Holdings (ORGO) Revenue Growth (3y) (2020 - 2026)
Organogenesis Holdings (ORGO) Revenue Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 2.22% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 4.22% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.31% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 9.51% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.40% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 28.43% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 8.98% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Organogenesis Holdings | 241.78 Mn | 194.94 Mn | 20.08 Mn | -28.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -28.02% |
| Mar 31, 2026 | -29.81% |
| Dec 31, 2025 | 25.00% |
| Sep 30, 2025 | 8.89% |
| Jun 30, 2025 | -5.95% |
| Mar 31, 2025 | -3.71% |
| Dec 31, 2024 | -0.31% |
| Sep 30, 2024 | 0.42% |
| Jun 30, 2024 | 1.87% |
| Mar 31, 2024 | 2.36% |
| Dec 31, 2023 | -2.29% |
| Sep 30, 2023 | 2.49% |
| Jun 30, 2023 | 19.38% |
| Mar 31, 2023 | 20.36% |
| Dec 31, 2022 | -20.68% |
| Sep 30, 2022 | -19.17% |
| Jun 30, 2022 | -17.15% |
| Mar 31, 2022 | -21.40% |
| Dec 31, 2021 | 26.21% |
| Sep 30, 2021 | 30.85% |